Page last updated: 2024-11-02

pioglitazone and Arterial Inflammation

pioglitazone has been researched along with Arterial Inflammation in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamblin, M1
Chang, L1
Zhang, H1
Yang, K1
Zhang, J1
Chen, YE1

Other Studies

1 other study available for pioglitazone and Arterial Inflammation

ArticleYear
Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formation.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:2

    Topics: Animals; Arteritis; Carotid Arteries; Cell Adhesion; Mice; Mice, Inbred CBA; Mice, Knockout; Mice, T

2011